Skip to main content
Top

Journal of Hematology & Oncology

Issue 1/2008

Content (27 Articles)

Open Access Research

Low-level expression of HER2 and CK19 in normal peripheral blood mononuclear cells: relevance for detection of circulating tumor cells

Fanglei You, Lisa A Roberts, S Peter Kang, Raquel A Nunes, Cinara Dias, J Dirk Iglehart, Natalie A Solomon, Paula N Friedman, Lyndsay N Harris

Open Access Case report

Aggressive juvenile fibromatosis of the paranasal sinuses: case report and brief review

Shaheen E Lakhan, Robert M Eager, Lindsey Harle

Open Access Research

Effect of Ras Inhibition in Hematopoiesis and BCR/ABL Leukemogenesis

Karina J Baum, Ruibao Ren

Open Access Research

Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways

Quanyi Lu, Xianghua Lin, Jean Feng, Xiangmin Zhao, Ruth Gallagher, Marietta Y Lee, Jen-Wei Chiao, Delong Liu

Open Access Research

Rosai dorfman disease of the orbit

Geeta K Vemuganti, Milind N Naik, Santosh G Honavar

Open Access Research

Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function

Wing Keung Chan, Christopher Ching Hang Cheung, Helen Ka Wai Law, Yu Lung Lau, Godfrey Chi Fung Chan

Open Access Short report

Detection of NPM1 exon 12 mutations and FLT3 – internal tandem duplications by high resolution melting analysis in normal karyotype acute myeloid leukemia

Angela YC Tan, David A Westerman, Dennis A Carney, John F Seymour, Surender Juneja, Alexander Dobrovic

Open Access Review

Novel therapies in genitourinary cancer: an update

David Chu, Shenhong Wu

Open Access Research

Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts

Lydia Usha, Bita Tabesh, Larry E Morrison, Ruta D Rao, Kris Jacobson, April Zhu, Sanjib Basu, John S Coon

Open Access Research

Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.

Majid Khalaf, Hani Abdel-Nabi, John Baker, Yiping Shao, Dominick Lamonica, Jayakumari Gona

Open Access Research

Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma

David J Tate Jr, Derek J Vonderhaar, Yupanqui A Caldas, Toye Metoyer, John R Patterson IV, Diego H Aviles, Arnold H Zea

Open Access Review

Novel therapies in breast cancer: what is new from ASCO 2008

David Chu, Janice Lu

Open Access Case report

Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: A case report

Brian J So, Tanios Bekaii-Saab, Mark A Bloomston, Tushar Patel

Open Access Research

Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells

Che K Lim, Li Sun, Qi Feng, Ping Law, Wei T Chua, Shy N Lim, William YK Hwang

Open Access Case report

A dramatic, objective antiandrogen withdrawal response: case report and review of the literature

Yiu-Keung Lau, Manpreet K Chadha, Alan Litwin, Donald L Trump

Open Access Editorial

Treatment of stage I seminoma: is it time to change your practice?

Darren R Feldman, George J Bosl

Open Access Case report

Left sided inferior vena cava duplication and venous thromboembolism: case report and review of literature

Cannon Milani, Maria Constantinou, David Berz, James N Butera, Gerald A Colvin

Open Access Research

Possible immunotherapeutic potentiation with D-Fraction in prostate cancer cells

Paul Pyo, Brandon Louie, Srinivas Rajamahanty, Muhammad Choudhury, Sensuke Konno

Open Access Case report

Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature

Utkarsh Acharya, Jen-Tzer Gau, William Horvath, Paolo Ventura, Chung-Tsen Hsueh, Wayne Carlsen

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine